Located at 801 West Girard Avenue Hawthorne Building, 4th Floor in Philadelphia, Pennsylvania, North Philadelphia Health Systems – DD/FI is a nonprofit addiction treatment provider. The DD/FI program is operated by North Philadelphia Health Systems.
Its services include detox (medically supervised withdrawal), residential (inpatient) treatment, hospital inpatient care, medication-assisted treatment (MAT), and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and motivational interviewing. For opioid use disorder, the program uses buprenorphine and naltrexone. It also prescribes medication for alcohol use disorder.
Payment options include government funding for substance use treatment, cash or self-payment, and state-financed health insurance plan other than Medicaid. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for young adults, pregnant/postpartum women, and criminal justice (other than DUI/DWI)/Forensic clients. Services are available in Spanish. Sign language services are available for deaf and hard-of-hearing clients.
North Philadelphia Health Systems – DD/FI is accredited by The Joint Commission and licensed or certified by the state substance use treatment agency, state department of health, and drug Enforcement Agency (DEA).
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.